Prof. Dr. Chris H. Bangma is urologist and Professor of the Department of Urology at Erasmus University Medical Centre in Rotterdam, The Netherlands. Mr. Bangma has extensive experience as a Principle Investigator in early phase clinical trials and international surveillances in prostate cancer. He chaired several consortia and working groups such as the European Fifth Framework Program from 2000, the GIANT consortium within the European Sixth Framework Program. Mr. Bangma is the founder of the first multidisciplinary prostate centre in the Netherlands in 2010, and the network raised following named Prostate Partners (2014). In 2018 he initiated the Anser Prostate Network, an official cooperation of 9 major hospitals in Holland with centralization of surgical treatment in the Anser Clinic. Currently he is director of the Anser Prostate Network. He has contributed to over 300 peer reviewed papers predominantly in the field of prostate and bladder carcinoma. As past President of the Dutch Urologic Society, he is Chairman of the Dutch Convent of Academic Professors in Urology, and has initiated the construction of the Dutch Urologic Research Organization. Amongst memberships of societies and committees, he is a member of AAGUS (2006) and till 2020 member of the Scientific Committee of the EAU. Mr. Bangma was granted a research fellowship on gene therapy for prostate cancer by the Dutch Cancer Society, and spent a two-year period at Baylor College of Medicine, Houston, USA, with Prof Timothy Thompson and Peter Scardino, and afterwards at the oncology lab of Prof. Bob Pinedo at the Free University in Amsterdam.